ATE424824T1 - Verfahren zur verhütung oder behandlung von herzarrhythmie - Google Patents
Verfahren zur verhütung oder behandlung von herzarrhythmieInfo
- Publication number
- ATE424824T1 ATE424824T1 AT03713563T AT03713563T ATE424824T1 AT E424824 T1 ATE424824 T1 AT E424824T1 AT 03713563 T AT03713563 T AT 03713563T AT 03713563 T AT03713563 T AT 03713563T AT E424824 T1 ATE424824 T1 AT E424824T1
- Authority
- AT
- Austria
- Prior art keywords
- preventing
- treating cardiac
- arhythmia
- cardiac arhythmia
- vanoxerine
- Prior art date
Links
- 230000000747 cardiac effect Effects 0.000 title 1
- NAUWTFJOPJWYOT-UHFFFAOYSA-N vanoxerine Chemical compound C1=CC(F)=CC=C1C(C=1C=CC(F)=CC=1)OCCN1CCN(CCCC=2C=CC=CC=2)CC1 NAUWTFJOPJWYOT-UHFFFAOYSA-N 0.000 abstract 2
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010003119 arrhythmia Diseases 0.000 abstract 1
- 239000002207 metabolite Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229950007136 vanoxerine Drugs 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
Landscapes
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Chemical Or Physical Treatment Of Fibers (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10/079,485 US6743797B2 (en) | 2002-02-22 | 2002-02-22 | Methods for treating cardiac arrhythmia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE424824T1 true ATE424824T1 (de) | 2009-03-15 |
Family
ID=27752750
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT03713563T ATE424824T1 (de) | 2002-02-22 | 2003-02-21 | Verfahren zur verhütung oder behandlung von herzarrhythmie |
Country Status (9)
| Country | Link |
|---|---|
| US (5) | US6743797B2 (de) |
| EP (2) | EP1485096B1 (de) |
| JP (1) | JP4565841B2 (de) |
| AT (1) | ATE424824T1 (de) |
| AU (1) | AU2003217607B2 (de) |
| CA (2) | CA2696267A1 (de) |
| DE (1) | DE60326548D1 (de) |
| NZ (1) | NZ535334A (de) |
| WO (1) | WO2003072030A2 (de) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6743797B2 (en) * | 2002-02-22 | 2004-06-01 | Chantest, Inc. | Methods for treating cardiac arrhythmia |
| US20050054010A1 (en) * | 2003-07-15 | 2005-03-10 | Brown Arthur M. | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| US7211407B2 (en) * | 2003-07-15 | 2007-05-01 | Chan Test, Inc. | High throughput assay systems and methods for identifying agents that alter surface expression of integral membrane proteins |
| JP2007534300A (ja) * | 2003-07-15 | 2007-11-29 | チャンエクスプレス インコーポレイテッド | 内在性膜タンパク質の表面発現を変える薬剤を特定するためのハイスループットアッセイシステムおよび方法 |
| US20090143434A1 (en) * | 2007-12-03 | 2009-06-04 | Brown Arthur M | Methods of using domperidone to terminate acute episodes of cardiac arrhythmia, to restore normal sinus rhythm or heart rate, to prevent recurrence of cardiac arrhythmia and to maintain normal sinus rhythm or heart rate in mammals |
| US20120010216A1 (en) * | 2010-07-06 | 2012-01-12 | Brown Arthur M | Pharmaceutical compositions containing vanoxerine |
| US20120028992A1 (en) * | 2010-08-02 | 2012-02-02 | Brown Arthur M | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia and/or maintaining normal sinus rhythm in mammals |
| JO3192B1 (ar) * | 2011-09-06 | 2018-03-08 | Novartis Ag | مركب بنزوثيازولون |
| US20150336917A1 (en) * | 2012-10-11 | 2015-11-26 | Laguna Pharmaceuticals, Inc. | Novel piperazine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals |
| US20150283131A1 (en) * | 2012-10-11 | 2015-10-08 | Chanrx Corporation | Pharmaceutical compositions containing piperazine compounds in combination with a p450 inhibitor and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| WO2014059367A1 (en) * | 2012-10-11 | 2014-04-17 | Chanrx Corporation | Pharmaceutical compositions containing enantiomerically pure and/or racemic mixtures of chiral piperazine compounds and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals through administration of said compositions |
| WO2014176557A2 (en) * | 2013-04-26 | 2014-10-30 | Chanrx Corporation | Methods for calibrating the administration of vanoxerine for terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythm in mammals |
| WO2014176497A1 (en) * | 2013-04-26 | 2014-10-30 | Chanrx Corporation | Novel metabolites of vanoxerine compounds, pharmaceutical compositions containing the same and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rhythm in mammals |
| US20160303114A1 (en) * | 2013-04-26 | 2016-10-20 | Laguna Pharmaceuticals, Inc. | Pharmaceutical compositions containing vanoxerine and p450 inhibitors and methods of terminating acute episodes of cardiac arrhythmia, restoring normal sinus rhythm, preventing recurrence of cardiac arrhythmia and maintaining normal sinus rythym in mammals through administration of said compositions |
| WO2015119938A1 (en) * | 2014-02-05 | 2015-08-13 | Chanrx Corporation | Pharmaceutical compositions for terminating acute episodes of cardiac arrhythmia, restoring sinus rhythm, preventing recurrence of cardiac arrhythmia, and/or maintaining normal sinus rhythm in mammals |
| KR101617683B1 (ko) | 2015-01-09 | 2016-05-03 | 연세대학교 산학협력단 | 부정맥 치료제 효과 평가 시스템 및 방법 |
| WO2019147889A1 (en) * | 2018-01-26 | 2019-08-01 | Brown Arthur M | Compositions and methods for treating atrial fibrillation and/or atrial flutter in a human |
| WO2019147890A1 (en) * | 2018-01-26 | 2019-08-01 | Brown Arthur M | Compositions and methods for preventing the recurrence of atrial fibrillation and/or atrial flutter in a human |
| CN111329860A (zh) * | 2019-03-01 | 2020-06-26 | 杭州健石药业有限公司 | Vanoxerine在持续性房颤的药中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1545094A (en) | 1976-12-14 | 1979-05-02 | Gist Brocades Nv | Piperazine derivatives |
| NL8202636A (nl) | 1982-06-29 | 1984-01-16 | Gist Brocades Nv | Piperazinederivaten, werkwijzen ter bereiding daarvan en farmaceutische preparaten die deze verbindingen bevatten. |
| HU196194B (en) | 1986-04-28 | 1988-10-28 | Richter Gedeon Vegyeszet | Process for producing new 1-4 disubstituted piperazines and pharmaceuticals comprising the compounds |
| WO1991001732A1 (en) | 1989-08-03 | 1991-02-21 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | Slowly dissociating (tight binding) dopamine, serotonin or norepinephrine reuptake inhibitors as cocaine, amphetamine and phencyclidine antagonists |
| DE19547263C2 (de) * | 1995-12-07 | 1999-04-29 | Cardiotec Inc | Amidinohydrazone vom Benzo[b]furan abgeleiteter Ketone, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel |
| GB9705428D0 (en) | 1997-03-15 | 1997-04-30 | Knoll Ag | Therapeutic agents |
| WO1999059594A1 (en) * | 1998-05-15 | 1999-11-25 | Merck & Co., Inc. | Potassium channel agonists |
| ATE387222T1 (de) * | 2000-07-14 | 2008-03-15 | Merck & Co Inc | Radioliganden- und bindungs-assay |
| EP1324780A4 (de) | 2000-09-06 | 2005-06-22 | Univ Johns Hopkins | Methoden zur behandlung von herzarrhythmie |
| US6743797B2 (en) * | 2002-02-22 | 2004-06-01 | Chantest, Inc. | Methods for treating cardiac arrhythmia |
-
2002
- 2002-02-22 US US10/079,485 patent/US6743797B2/en not_active Expired - Lifetime
-
2003
- 2003-02-21 NZ NZ535334A patent/NZ535334A/en not_active IP Right Cessation
- 2003-02-21 CA CA2696267A patent/CA2696267A1/en not_active Abandoned
- 2003-02-21 EP EP03713563A patent/EP1485096B1/de not_active Expired - Lifetime
- 2003-02-21 WO PCT/US2003/005138 patent/WO2003072030A2/en not_active Ceased
- 2003-02-21 AU AU2003217607A patent/AU2003217607B2/en not_active Ceased
- 2003-02-21 JP JP2003570777A patent/JP4565841B2/ja not_active Expired - Fee Related
- 2003-02-21 EP EP09000064A patent/EP2052722A1/de not_active Withdrawn
- 2003-02-21 CA CA2476996A patent/CA2476996C/en not_active Expired - Fee Related
- 2003-02-21 DE DE60326548T patent/DE60326548D1/de not_active Expired - Lifetime
- 2003-02-21 AT AT03713563T patent/ATE424824T1/de not_active IP Right Cessation
- 2003-12-23 US US10/742,822 patent/US20040138146A1/en not_active Abandoned
-
2007
- 2007-07-25 US US11/878,611 patent/US7700600B2/en not_active Expired - Fee Related
-
2009
- 2009-11-12 US US12/591,180 patent/US20100069403A1/en not_active Abandoned
-
2011
- 2011-06-13 US US13/158,791 patent/US8450325B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| EP1485096A2 (de) | 2004-12-15 |
| US20100069403A1 (en) | 2010-03-18 |
| DE60326548D1 (de) | 2009-04-23 |
| AU2003217607B2 (en) | 2008-08-14 |
| US20080214554A1 (en) | 2008-09-04 |
| AU2003217607A1 (en) | 2003-09-09 |
| WO2003072030A2 (en) | 2003-09-04 |
| US20030162793A1 (en) | 2003-08-28 |
| EP2052722A1 (de) | 2009-04-29 |
| US8450325B2 (en) | 2013-05-28 |
| US20110237604A1 (en) | 2011-09-29 |
| CA2696267A1 (en) | 2003-09-04 |
| US20040138146A1 (en) | 2004-07-15 |
| EP1485096A4 (de) | 2007-07-11 |
| CA2476996A1 (en) | 2003-09-04 |
| WO2003072030A3 (en) | 2004-01-22 |
| JP2005524646A (ja) | 2005-08-18 |
| JP4565841B2 (ja) | 2010-10-20 |
| NZ535334A (en) | 2006-04-28 |
| US7700600B2 (en) | 2010-04-20 |
| EP1485096B1 (de) | 2009-03-11 |
| CA2476996C (en) | 2011-02-15 |
| US6743797B2 (en) | 2004-06-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60326548D1 (de) | Verfahren zur verhütung oder behandlung von herzarrhythmie | |
| ATE517632T1 (de) | Niedrigdosierte verfahren zur behandlung von erkrankungen, bei denen tnf-alpha-aktivität schädlich ist | |
| CY1120977T1 (el) | Θεραπεια των ασθενειων αποθηκευσης γλυκογονου τυπου ιι | |
| ATE499934T1 (de) | Verwendung von (3.2.0) heterocyclischen verbindungen und ihren analoga zur behandlung von krebs | |
| ATE355374T1 (de) | Therapeutische agentien und methoden ihrer verwendung zur behandlung von amyloidogenen erkrankungen | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| ATE320803T1 (de) | Verfahren zur behandlung von alzheimerschen krankheit | |
| CY1109191T1 (el) | Μια νεα χρηση της δεφεριπρονης | |
| ATE399782T1 (de) | Zur behandlung von schmerzen geeignete phenylcarbonsäureamidverbindungen | |
| DE602004017481D1 (de) | Zur behandlung von schmerzen geeignete therapeutische mittel | |
| BR0308813A (pt) | Tratamento de tuberculose usando derivados de pleuromutilina | |
| NO20024646L (no) | Kombinasjonsterapier med vaskul¶r-skadende aktivitet | |
| ATE422357T1 (de) | Verwendung von allopurinol zur behandlung von bluthochdruck | |
| RU94044490A (ru) | Применение 2-фенил-3-ароилбензотиофенов для подавления дефектного восстановления ткани | |
| BR0316458A (pt) | Composto, composição farmacêutica, método de tratamento ou prevenção de doenças, método para intensificar a cognição em um paciente saudável, e, uso de um composto | |
| DE60218843D1 (de) | Verfahren zur identifizierung von mitteln zur behandlung von diabetes | |
| EP1499190A4 (de) | Verfahren zur behandlung von lebererkrankungen und leberschäden mit wachstumshormon und foxm1b | |
| ATE281841T1 (de) | Verfahren zur herstellung von mikania extrakten enthaltend mikanolide und dihydromikanolide und verwendung in der behandlung proliferativer erkrankungen | |
| ATE250936T1 (de) | Verfahren zur behandlung von erkrankungen oder störungen des innenohrs | |
| CA2585266A1 (en) | Ophthalmic compositions and methods of using the same | |
| ATE516040T1 (de) | Zusammensetzung und verwendung zur vorbeugung oder behandlung von stomatitis | |
| ATE257384T1 (de) | Verwendung von cilobradine oder pharmazeutisch akzeptablen salze zur behandlung oder prävention von herzversagen | |
| RU94011321A (ru) | Способ профилактики и лечения заболеваний кожи | |
| ATE268170T1 (de) | Verwendung von bernsteisäure oder deren salze zur behandlung von insulinresistenz | |
| DE69734349D1 (de) | Behandlung von knochenleiden mit adrenomedullin |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |